MedPath
NMPA Approval

Beclometasone Dipropionate and Formoterol Fumarate Powder for Inhalation

国药准字HJ20240144

December 1, 2024

Drug Information

倍氯米松福莫特罗吸入粉雾剂

吸入粉雾剂

每个吸入器120吸,每吸含丙酸倍氯米松100μg和富马酸福莫特罗6μg,递送剂量为丙酸倍氯米松81.9μg和富马酸福莫特罗5.0μg。

化学药品

December 1, 2024

November 30, 2029

Company Information

Applicant Company

Via Palermo 26/A-43122 Parma, Italia

Manufacturing Company

Via San Leonardo, 96-43122 Parma, Italia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

倍氯米松福莫特罗吸入粉雾剂 - NMPA 批准文号 | MedPath